release tablets

A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product (Pristiqâ„¢ 50 mg) in Healthy Thai Volunteers under Fasting Conditions - Pilot Study

An Open Label, Randomized, Two-treatment, Two-period, Two-sequence, Multiple Oral Dose, Crossover Bioequivalence Study of Generic Desvenlafaxine 50 mg Extended-release Tablets and Reference Product (Pristiqâ„¢ 50 mg) in Healthy Thai Volunteers under Fasting Conditions

Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Tramadol Hydrochloride 100 mg Extended-Release Tablets Formulations, Tramal retard 100 mg and TRAMADOL RETARD GPO (100 MG), after Oral Administration to Healthy Thai Volunteers under Fasting Conditions

Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Metformin Hydrochloride 1000 mg Extended-Release Formulation, Glucophage XR 1000 mg and Metformin XR (1000 mg), After Oral Administration to Healthy Thai Volunteers Under Fasting Conditions

Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Carvedilol 6.25 mg Tablets Formulations, Dilatrend and Carvolol (6.25 mg), after Oral Administration to Healthy Thai Volunteers under Fasting Conditions

An Open Label, Randomized, Two-Treatment, Two-Period, Two-Sequence, Single Oral Dose, Crossover Bioequivalence Study of Darutab (Darunavir 600 mg) Tablets of The Government Pharmaceutical Organization, Bangkok, Thailand, with Prezista (Darunavir 600 mg) Tablets of Janssen Ortho LLC, Gurabo, Puerto Rico with Co-Administration of Norvir (Ritonavir 100 mg) Tablets in Normal, Healthy, Adult, Human Subjects under Fed Conditions

AN OPEN LABEL, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, SINGLE ORAL DOSE, CROSSOVER BIOEQUIVALENCE STUDY OF QUAPINE (QUETIAPINE 100 MG) TABLETS OF THE GOVERNMENT PHARMACEUTICAL ORGANIZATION, BANGKOK, THAILAND WITH SEROQUEL (QUETIAPINE 100 MG) TABLETS OF ASTRAZENECA PHARMACEUTICALS CO., LTD., JIANGSU, PEOPLE'S REPUBLIC OF CHINA, IN NORMAL, HEALTHY, ADULT HUMAN SUBJECTS UNDER FASTING CONDITIONS

Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Sofosbuvir 400 mg Tablets Formulations, Sovaldi and HEPASOF (400 mg), after Oral Administration to Healthy Thai Volunteers under Fasting Conditions